| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jul―10 |
The Heterogenous Presentations of De Novo and Recurrent Ocular Inflammation following COVID-19 Vaccination: A Multicenter Report and Review of the Literature |
Sruthi Arepalli, Akshay Thomas |
| 2 |
[GO] |
2025―Jul―01 |
The Heterogeneous Presentations of De Novo and Recurrent Ocular Inflammation following COVID-19 Vaccination |
Hinpetch Daungsupawong, Viroj Wiwanitkit |
| 3 |
[GO] |
2025―Jan―22 |
The Heterogeneous Presentations of De Novo and Recurrent Ocular Inflammation following COVID-19 Vaccination: A Multi-Center Report and a Review of the Literature |
Sruthi Arepalli, Laura Kopplin, Edmund Tsui, Daniel Brill, Lucia Sobrin, George Papaliodis, et al. (+7) Dana Darwish, Veena Raiji, Priya Janardhana, Parisa Emami-Naeini, Lish Nore, Meredith Parker, Akshay S. Thomas |
| 4 |
[GO] |
2024―Apr―29 |
Response to: Retinal vascular occlusion during the pandemic requires thorough investigation of its causes |
Adrianna U. Dera, Tobias Brockmann, Wladislaw Rusch, Ada L. Weiland, Emil C. Reisinger, Thomas A. Fuchsluger, Claudia Brockmann |
| 5 |
[GO] |
2024―Apr―29 |
Retinal vascular occlusion during the pandemic requires thorough investigation of its causes |
Sounira Mehri, Josef Finsterer |
| 6 |
[GO] |
2024―Feb―12 |
Retinal vein occlusions before and during the COVID-19 pandemic. Visual outcomes and treatment patterns in a country with no mandatory lockdown. |
Anna Cullhed Farrell, David Epstein |
| 7 |
[GO] |
2023―Oct―12 |
RETINAL VASCULAR OCCLUSION AND COVID-19 DIAGNOSIS |
Jing-Xing Li, James Cheng-Chung Wei, Yu-Hsun Wang, Henry Bair, Shu-Bai Hsu, Chun-Ju Lin |
| 8 |
[GO] |
2023―Aug―03 |
Prevalence of SARS-CoV-2 RNA and antibody-detection, and vaccination status in patients with ocular vascular occlusion |
Adrianna U. Dera, Tobias Brockmann, Wladislaw Rusch, Ada L. Weiland, Emil C. Reisinger, Thomas A. Fuchsluger, Claudia Brockmann |
| 9 |
[GO] |
2023―Feb―02 |
Diagnostic and Therapeutic Challenges: Is it SARS-CoV-2 infection followed by delayed Inflammation? |
Atul Arora, Mohit Dogra, Aman Sharma, Simar Rajan Singh, Rupesh Agrawal, Piergiorgio Neri, Vishali Gupta |
| 10 |
[GO] |
2022―May―03 |
COVID-19 Pandemic Lockdowns Impact on Visual Acuity of Neovascular AMD Patients: A Large cohort |
Reut Shor, Ori Segal, Michael Mimouni, Eran Greenbaum, Dinah Zur, Omer Trivizki, et al. (+4) Shulamit Schwartz, Anat Loewenstein, Michaella Goldstein, Gilad Rabina |
| 11 |
[GO] |
2022―Feb―25 |
Posterior segment ocular findings in critically ill COVID-19 patients |
Rosa María Romero-Castro, Matilde Ruiz-Cruz, Claudia Alvarado-de la Barrera, María Gabriela González-Cannata, Yara Andrea Luna Villalobos, Ana Karen García-Morales, et al. (+3) Yuria Ablanedo-Terrazas, Mauricio González-Navarro, Santiago Ávila-Ríos |
| 12 |
[GO] |
2022―Feb―17 |
Regional population mobility and outpatient retina visits in the United States during the COVID-19 pandemic |
Rebecca Russ Soares, Charles Huang, Nick Boucher, Nitika Aggarwal, Rusirini Fernando, John Hinkle, et al. (+6) Joseph DeSimone, Louis Cai, Samir N. Patel, David Xu, Ajay E. Kuriyan, Yoshihiro Yonekawa |
| 13 |
[GO] |
2021―Dec―15 |
Myths and Truths of the association of retinal vascular occlusion with COVID-19 |
Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Mario R. Romano, Barbara Parolini, Sengul Ozdek, et al. (+4) Mohamed A Tawfik, Ameen Marashi, Baruch D Kuppermann, Quan Dong Nguyen |
| 14 |
[GO] |
2021―Dec―15 |
Treatment deferral during COVID-19 lockdown |
Andrea Montesel, Anthony Gigon, Clarice Giacuzzo, Irmela Mantel, Chiara M. Eandi |
| 15 |
[GO] |
2021―Dec―15 |
International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes |
Javier Zarranz-Ventura, Vuong Nguyen, Catherine Creuzot-Garcher, Frank Verbraak, Louise O´Toole, Alessandro Invernizzi, et al. (+4) Francesco Viola, David Squirrel, Daniel Barthelmes, Mark C. Gillies |
| 16 |
[GO] |
2021―Oct―29 |
Characterizing COVID-19-related retinal vascular occlusions |
Alex Fonollosa, José Hernández-Rodríguez, Carlos Cuadros, Lena Giralt, Cristina Sacristán, Joseba Artaraz, et al. (+13) Laura Pelegrín, Álvaro Olate-Pérez, Rosa Romero, Salvador Pastor-Idoate, Eva María Sobas, Sonia Fernández-Fidalgo, Maximino J. Abraldes, Andrea Oleñik, Alfredo Insausti-García, Pedro Torres, Carmela Porcar, Daniela Rego Lorca, Alfredo Adan |
| 17 |
[GO] |
2021―Oct―29 |
Low vulnerability of the posterior eye segment to SARS-CoV-2 infection |
Steffen Emil Künzel, Thore Bürgel, Sandrine Helene Künzel, Dominika Pohlmann, Oliver Zeitz, Antonia Joussen, Alexandre Dubrac |
| 18 |
[GO] |
2021―Aug―09 |
Outcomes in Patients Resuming Intravitreal Anti-VEGF Therapy Following Treatment Delay during the COVID-19 Pandemic |
Ryan B. Rush, Sloan W. Rush |
| 19 |
[GO] |
2021―Aug―09 |
Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection |
Tamar Rabinovitch, Yael Ben-Arie-Weintrob, Tamar Hareuveni-Blum, Boaz Shaer, Vicktoria Vishnevskia-Dai, Shiri Shulman, et al. (+7) Hadas Newman, Muhammad Biadsy, Dua Masarwa, Naomi Fischer, Oren Yovel, Shalhevet Goldfeather- Ben Zaken, Zohar Habot-Wilner |
| 20 |
[GO] |
2021―May―10 |
“Face mask contamination during COVID-19 pandemia. Study on patients receiving intravitreal injections” |
Juan Marin-Nieto, Carmen Reino-Perez, Genoveva Santillana-Cernuda, José Manuel Díaz-Bernal, Rafael Luque-Aranda, Ignacio García-Basterra |
| 21 |
[GO] |
2021―May―09 |
Endophthalmitis after intravitreal injections during the COVID-19 pandemic with implementation of universal masking |
Mina M. Naguib, Sophia Ghauri, Anirudh Mukhopadhyay, Amy C. Schefler |
| 22 |
[GO] |
2021―Mar―18 |
Endogenous endophthalmitis in the setting of Covid-19 infection |
Alper Bilgic, Aditya Sudhalkar, Jesus H. Gonzalez-Cortes, Francesc March de Ribot, Rohit Yogi, Laurent Kodjikian, Thibaud Mathis |
| 23 |
[GO] |
2020―Aug―20 |
Retina Practice in a Pandemic |
Emmett T. Cunningham, Alexander J. Brucker |
| 24 |
[GO] |
2020―Aug―14 |
The impact of coronavirus disease (COVID-19) pandemic on intravitreal injections treatment for macular diseases |
Francesco Viola, Paolo Milella, Francesco Pozzo Giuffrida, Simone Ganci, Alessandro Invernizzi |
| 25 |
[GO] |
2020―Jul―29 |
CAN WE SAFETLY USE GAS AS ENDOTAMPONADING AGENT IN VITREORETINAL SURGERY DURING CORONAVIRUS DISEASE (COVID-19) PANDEMIC? |
Claudio Furino, Francesco Boscia, Michele Reibaldi, Giovanni Alessio |